Diclofenac deanol

• UNSPSC Description:

  Diclofenac deanol (DDNL) is a nonsteroidal anti-inflammatory drug with anti-inflammatory, analgesic and antipyretic activities. Diclofenac deanol has a more potent inhibitory effect on cyclooxygenase (COX)-2 than on COX-1. The solubility of diclofenac deanol is significantly higher than that of other diflunisal salts reported earlier. Diclofenac deanol has a wide range of potential applications in the medical field due to its biological activity and high water solubility[1].

• Target Antigen:

  COX

• Type:

  Reference compound

• Related Pathways:

  Immunology/Inflammation

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/diclofenac-deanol.html

• Smiles:

  O=C(CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1)O.OCCN(C)C

• Molecular Weight:

  385.28

• References & Citations:

  [1]Preparation and characterisation of a range of diclofenac salts

• Shipping Conditions:

  Room temperature

• Clinical Information:

  Phase 4

• CAS Number:

  81811-14-5